PMN
ProMIS Neurosciences Inc.Company with tickers: PMN
CIK
1374339
CUSIP
74346M505
Shares Outstanding
8,967,693
Investor Relations
https://www.promisneurosciences.com/investors
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Slanix Alex, Pharm.D | director | Appointed | 2026-05-20 |
| William Wyman | director | Appointed | 2026-05-20 |
| Neil K. Warma | director | Appointed | 2026-05-20 |
| Maggie Shafmaster, Ph.D., J.D. | director | Appointed | 2026-05-20 |
| Joshua Mandel-Brehm | director | Appointed | 2026-05-20 |
| Neil Cashman, M.D. | director | Appointed | 2026-05-20 |
| Eugene Williams | director | Appointed | 2026-05-20 |